Boston University Clinical and Translational Science Institute

波士顿大学临床与转化科学研究所

• 批准号: 9261614
• 负责人: Darrell N. Kotton
• 金额: $ 56.88万
• 依托单位: BOSTON UNIVERSITY MEDICAL CAMPUS
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-08-13 至 2019-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9261614
• 关键词: Address; Adopted; Affinity; Area; Basic Science; Biological; Biomedical Engineering; Biomedical Research; Bone Regeneration; Boston; Cardiology; Clinical; Clinical Sciences; Collaborations; Competence; Conscious; Dentistry; Dermatologic; Dermatology; Development; Discipline; Doctor of Philosophy; Drug Delivery Systems; Educational Curriculum; Effectiveness; Environment; Faculty; Financial Support; Floor; Fostering; Foundations; Framingham Heart Study; Funding; Future; Gastroenterology; Geriatrics; Goals; Hematology; Home environment; Industry; Institutes; Institution; Intention; International; Laboratories; Leadership; Learning; Medical; Medicine; Mentors; Mission; Molecular Medicine; Operative Surgical Procedures; Orthopedics; Outcome; Patients; Pediatrics; Performance; Peripheral; Pharmaceutical Preparations; Phenotype; Play; Positioning Attribute; Postdoctoral Fellow; Process; Productivity; Program Evaluation; Publications; Pulmonology; Regenerative Medicine; Research; Research Personnel; Research Training; Resources; Role; Science; Scientist; Section 8; Secure; Shapes; Sickle Cell; Stem Cell Research; Stem cells; Students; Study Subject; TNFSF15 gene; Teaching Method; Technology; Time; Toxicity Tests; Training; Training Programs; Translational Research; Universities; Vision; Vocational Guidance; Workforce Development; base; bench to bedside; career; career development; cell bank; design; education research; efficacy testing; experience; foot; human disease; innovation; interdisciplinary approach; interest; medical schools; member; mid-career faculty; multidisciplinary; oncology; personalized medicine; physical science; pre-doctoral; programs; skills; success; teacher; tool; translational medicine; translational pipeline

The overarching concepts and goals of the Regenerative Medicine Training Program (RMTP TL1) are to 1) provide an innovative, integrative and interdisciplinary training program for pre- doctoral and post-doctoral trainees which will leverage a unique and internationally recognized strength of BU, 2) establish an environment that facilitates translational team science interactions with trainees, MD scientists and clinicians, thereby synergistically bridging research strengths with interdisciplinary approaches in regenerative medicine, and 3) catapult BU into the forefront of institutions that are producing scientists with the skills and expertise to fulfill a current and future patient-based need for regenerative medicine. The objectives of our training program also align precisely with the general Boston University CTSI (BU CTSI) goals and with the strong emphasis on regenerative medicine at Boston University School of Medicine, as well as to further the mission of NCATS of expediting personalized medicine and the discovery and delivery of drugs to market. The RMTP will provide support for 3 pre-doctoral and 2 post- doctoral trainees each year, totaling 27 pre-doctoral and 18 post-doctoral trainees supported for the duration of the program, with each trainee participating for two years. Accepted trainees will be outstanding students/postdocs and selected based on grades/productivity, quality of the proposal, likely to pursue careers in academic regenerative medicine, highly motivated, energetic, and well-prepared for the curriculum. The curriculum will be competency-based and include rigorous training in didactic and laboratory based concepts and technology. An extensive and individualized mentoring plan will be implemented for each trainee that will included both scientific as well career development guidance. We fully anticipate that under the vision of “todays trainees are the teachers of tomorrow”, the RMTP will generate a continual influx of research and clinical leaders in the stem cell/regenerative medicine field who will make significant contributions resulting in the realization of its full medical potential. We seek to retain a major portion of our trainees, both in our own program and elsewhere, as investigators and mentors in regenerative medicine. Success of the RMTP will be based on the ability to increase the pipeline of well-trained scientists who continue their research in regenerative medicine, the number and quality of their publications, and leadership positions they assume in both industry and academic environments.

再生医学培训计划（RMTP）的总体概念和目标